1 UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA * * * * * * * * * * * * * * * * POLICY AND RESEARCH, LLC, et al. Plaintiffs, vs. DEPARTMENT OF HEALTH AND HUMAN SERVICES, Defendant. ) ) ) ) ) ) ) ) Civil Action No. 18-346 9:35 a.m. April 19, 2018 Washington, D.C. * * * * * * * * * * * * * * * * TRANSCRIPT OF ORAL RULING BEFORE THE HONORABLE KETANJI B. JACKSON, UNITED STATES DISTRICT COURT JUDGE APPEARANCES: FOR THE PLAINTIFFS: ALLISON MARCY ZIEVE SEAN M. SHERMAN Public Citizen Litigation Group 1600 20th Street, NW Washington, DC 20009 (202) 588-1000 Email: Azieve@citizen.org Email: Ssherman@citizen.org FOR THE GOVERNMENT: MICHAEL J. GERARDI JOEL McELVAIN United States Department of Justice Civil Division, Federal Programs Branch 20 Massachusetts Ave. NW, Room 7223 Washington, D.C. 20530 Tel: (202) 616-0680 E-mail: Michael.j.gerardi@usdoj.gov ALSO PRESENT (via telephone): Michael Quinn, Robert Charrow, Matt Bowman Brian Simpson, Jocelyn Mendelsohn, Jody Morris Elizabeth Saindon, Jonathan Jacobson Reporter: Elizabeth Saint-Loth, RPR, FCRR Official Court Reporter (202) 354-3242 Proceedings reported by machine shorthand, transcript produced by computer-aided transcription. 2 P R O C E E D I N G S 1 2 THE DEPUTY: Your Honor, this is Civil 3 Action 18-346, Policy & Research, LLC, et al. versus 4 Department of Health and Human Services, et al. 5 6 7 8 9 10 I'm going to ask counsel to approach the lectern and identify yourselves. MR. SHERMAN: On behalf of plaintiffs, Sean Sherman and Allison Zieve for Public Citizen. THE COURT: Good morning. MR. GERARDI: Good morning, Your Honor. On behalf 11 of Health and Human Services, Michael Gerardi and Joel 12 McElvain from the Department of Justice. 13 THE COURT: 14 THE DEPUTY: 15 16 17 18 19 20 21 22 23 24 25 Good morning to you as well. Would the parties on the phone please identify yourselves for the record. MR. QUINN: Yes. Good morning, Your Honor. Michael Quinn, U.S. Department of Justice. MR. CHARROW: Robert Charrow, Department of Health and Human Services. MR. BOWMAN: Matt Bowman, Department of Health and Human Services. MR. SIMPSON: Brian Simpson, Department of Health and Human Services. MS. MENDELSOHN: Health and Human Services. Jocelyn Mendelsohn, Department of 3 1 2 MS. SAINDON: Health and Human Services. 3 4 5 Elizabeth Saindon, Department of MR. JACOBSON: Jonathan Jacobson, Department of Justice. MS. MORRIS: Jody Morris, counsel for plaintiffs 6 in the Teen Pregnancy Prevention Program litigation in the 7 District of Maryland. 8 THE COURT: 9 Good morning. 10 All right. It sounds like everyone. As you know, the parties in this matter appeared 11 before me yesterday for a hearing regarding the pending 12 cross-motions for summary. 13 representations that I made at that time, I am now ready to 14 rule on these motions. Consistent with the 15 (The proceeding is paused.) 16 THE DEPUTY: The parties that are on the line, if 17 you don't mind, can you please mute your telephone because 18 any noise that you are making in the background is being 19 picked up by the court reporter. 20 your phones on mute. 21 THE COURT: 22 Let me say, again, that consistent with the We're asking that you put Thank you. 23 representations that I made yesterday, I am now ready to 24 rule on these motions. 25 detailed explanation of my decision in the form of a written I will be issuing a full and 4 1 opinion, and I hope to be able to turn that around 2 relatively quickly. 3 given the nature of the Government action that is being 4 challenged in this case, I will announce my ruling orally 5 now and provide some basic comments about the reasons for 6 it. 7 But because time is of the essence, First, though, to lay the groundwork for an 8 understanding of my findings and conclusions, I will briefly 9 describe the facts, the parties' arguments, and relevant 10 legal standards before I tell you what I have concluded, and 11 why. 12 First, the undisputed facts. 13 As you all are aware, the plaintiffs in this case 14 are a number of private nonprofit organizations that 15 submitted applications to HHS through a competitive process 16 for the receipt of grant funding. 17 the agency to participate in the agency's Teen Pregnancy 18 Prevention Program -- which you may hear me refer to as the 19 "TPPP" -- for the five-year project cycle that spans 2015 20 through 2020. 21 And they were selected by Each plaintiff proposed a program designed to 22 reduce the rate of teen pregnancy within certain 23 communities, and the agency programatically approved each 24 plaintiff's proposed project for a five-year period. 25 five-year projects were to be funded in discrete one-year The 5 1 increments known as "budget periods." 2 the agency's past practices, the actual funding was to be 3 allocated to each plaintiff on a yearly basis through a 4 legal document known as a Notice of Award, which HHS 5 provided to plaintiffs in 2015 and then, again, in 2016 in 6 response to each plaintiff's submission of a noncompeting 7 continuation application. 8 9 10 11 And consistent with The 2015 and 2016 Notices of Award funded plaintiff's projects during the fiscal years June 2015 through June 2016 and June 2016 to June 2017. In July of 2017, HHS issued Notices of Award to 12 plaintiffs concerning the funding for the 2017 to 2018 13 fiscal year. These notices allocated funding for that 14 fiscal year. But the notices also stated that "This award 15 shortens the project period to end on June 30, 2018 at the 16 end of this budget year." 17 The notice did not contain any reason or 18 explanation as to why the agency was shortening the project 19 period by two years. 20 plaintiffs had behaved in such a way as to provide a cause 21 for this determination. 22 And HHS has never suggested that Plaintiffs filed the instant lawsuit in light of 23 HHS's decision to shorten the project period and end the 24 period of performance of the grant awards. 25 that HHS's shortening decision was an arbitrary and Plaintiffs claim 6 1 capricious act, in violation of the Administrative 2 Procedures Act, both because the agency failed to explain 3 its reasons for what plaintiffs characterize as a 4 "termination" of their federal grants and because the agency 5 terminated the grants in a manner that was contrary to its 6 own regulations. 7 Plaintiffs also filed a preliminary injunction 8 that has been converted into a motion for summary judgment. 9 And HHS responded with a summary judgment motion of its own 10 arguing that the agency's announcement that it was 11 shortening the project period was not a termination for the 12 purpose of the regulations but, rather, a lawful 13 discretionary decision to withhold a noncompeting 14 continuation award under the agency's Grant Policy 15 Statement. 16 In fact, the agency contends that its action in 17 regard to the treatment of plaintiff's grant funding award 18 is so discretionary that the agency's decision is 19 effectively unreviewable because it is a matter that has 20 been committed to agency discretion by law. 21 Ultimately, as indicated in their briefs, and 22 again yesterday, the parties appear to agree that their 23 summary judgment arguments hinge on whether HHS's action is 24 best characterized as a termination of the plaintiff's 25 awards on the one hand or a withholding of noncompeting 7 1 2 continuation funds on the other. Notably and significantly, for present purposes, 3 HHS's regulations outline what constitutes a termination of 4 a Federal grant award and the instances in which the agency 5 can take that action. 6 45 CFR Sections 75.2 and 75.372. I am referring to the provisions in 7 Also significant is the fact that HHS's 8 regulations do not appear to speak to whether and under what 9 circumstances the agency can withhold a noncompeting 10 continuation award within an approved project period. 11 Again, the evidence that HHS has produced to argue 12 that the agency has the authority to withhold funding within 13 a competitive segment is its Grant Policy Statement which 14 does appear to distinguish between a suspension or 15 termination of a grant and a decision by the agency to 16 withhold a noncompeting continuation award. 17 Thus, the Court's first observation is that the 18 2017 Notice of Award and HHS's regulations and Grant Policy 19 Statement have put the agency in a difficult spot because, 20 in order to succeed on its motion, the agency must establish 21 that its decision to shorten the project period of 22 plaintiff's grants does not constitute termination under the 23 regulations and is not otherwise arbitrary or capricious. 24 25 In this regard, HHS vigorously maintains that its decision was neither a termination nor an arbitrary or 8 1 capricious exercise of its discretionary authority because 2 the Grant Policy Statement, which plaintiffs agreed to when 3 they drew down the funds, clearly states that the agency can 4 decide not to make a noncompeting continuation award if it 5 determines that "for whatever reason, continued funding 6 would not be in the best interests of the Federal 7 Government." 8 9 In response, plaintiffs' query why the Grant Policy Statement matters, when the regulations themselves 10 compel the conclusion that HHS's unexplained decision to 11 shorten the project period amounts to a termination that 12 violates both the APA and the enforceable standards that 13 cabin agency discretion under these circumstances. 14 15 16 17 18 Those were the basic facts and a bird's eye view of the parties' legal arguments. The Court now turns to the general standards that it has applied when reaching its conclusion in this case. When one or more parties request summary judgment 19 in the context of an APA case, the reviewing Court generally 20 reviews the challenge to the agency's decision as an 21 appellate Court addressing issues of law. 22 Court is grappling with a question of law, and only a 23 question of law. 24 to decide whether an agency's actions were consistent with 25 the relevant APA standard of review based on the This means that a And that kind of review requires the Court 9 1 administrative record, and the facts and reasons provided 2 therein. 3 In this case, like many APA cases, what is 4 involved is what courts typically refer to as the arbitrary 5 and capricious standard which requires the Court to set 6 aside final agency action that is "arbitrary, capricious, an 7 abuse of discretion, or otherwise not in accordance with 8 law." 9 that agencies must articulate a satisfactory explanation for And in this regard, the Supreme Court has long held 10 their actions, and that an agency must follow its own 11 regulations. 12 However, notably, a reviewing Court must sometimes 13 deal with threshold issues prior to delving into the merits 14 of a challenge under the APA. 15 contends that the Court does not have the ability to review 16 an agency's actions pursuant to Section 701(2) of the APA, 17 the Court must determine, as a threshold matter, whether the 18 agency's action is a reviewable one under the APA before it 19 addresses the merits of plaintiffs' APA claims. 20 If a defendant agency Of course, it is well established that there is an 21 initial presumption that a Court can review an agency's 22 actions under the APA. 23 as where the challenged agency decision is committed to 24 agency discretion by law, a Court cannot review whether the 25 agency has acted in accordance with the APA. But in certain circumstances, such 10 1 The Supreme Court has emphasized that the 2 committed to agency discretion by law exception is a very 3 narrow one and applies only in rare circumstances, 4 specifically when there are no statutory, regulatory, or 5 binding policy norms that constrain the agency's discretion 6 and thereby provide standards for the Court to apply. 7 In the event that the Court does find that the 8 agency's decision is reviewable, the Court then proceeds to 9 review the decision on the merits pursuant to the applicable 10 APA standards. 11 established that an agency acts arbitrarily and capriciously 12 if it failed to provide reasons for the challenged decision 13 or if its decision contravenes provisions of federal law. 14 And, as mentioned, it is by now well In this case, the parties have briefed three 15 separate issues, specifically: One, whether HHS's decision 16 to shorten the project period for the plaintiff's grants was 17 committed to agency discretion and, thus, is an unreviewable 18 determination under the APA; two, whether plaintiffs have 19 stated a plausible legal claim that HHS terminated the 20 plaintiffs' grants; and, three, whether HHS acted 21 arbitrarily and capriciously in shortening the project 22 period for plaintiffs' grants. 23 As the parties acknowledged at yesterday's motion 24 hearing, the first two arguments turn on a single question: 25 Has the agency terminated the plaintiffs' federal award 11 1 within the meaning of the HHS regulations? 2 Court will answer this question first in the context of 3 determining whether HHS's decision is reviewable under the 4 APA. 5 Therefore, this The Court's general analysis of reviewability 6 begins with the observation that, within the D.C. Circuit, 7 evaluating whether or not an agency's decision is committed 8 to agency discretion by law requires the Court to perform a 9 two-step analysis. First, the Court must consider the 10 nature of the administrative action at issue to determine 11 the status of the initial presumption, that is, whether 12 there is a presumption in favor of or against judicial 13 review of an agency's action. 14 determined which presumption applies, the Court looks to any 15 pertinent statutes, regulations, and formal or informal 16 policy statements to determine whether there are judicially 17 manageable standards that would allow the Court to evaluate 18 whether an agency has behaved in a lawful manner. 19 Then, once the Court has With respect to the presumption issue, it does 20 appear that the type of action that HHS took in this case, 21 its decision to change the grant funding that had previously 22 been provided to plaintiffs, is presumptively unreviewable. 23 In Lincoln versus Vigil, the Supreme Court 24 explained that, when it comes to funding decisions, an 25 agency's decisions of which programs to fund entails 12 1 "a complicated balancing of a number of factors which are 2 peculiarly within the agency's expertise, and agency's are 3 far better equipped than courts to deal with the many 4 variables involved in those decisions." 5 from 508 U.S. at 193. 6 That was a quote Moreover, Lincoln's rationale clearly applies to 7 instances where an agency has decided to discontinue funding 8 for a certain program or project. 9 the type of conduct that the federal agency in Lincoln had 10 11 Indeed, that is exactly taken. Now, admittedly, this case does differ from 12 Lincoln in that this case does not deal with a lump-sum 13 appropriation. 14 the allocation of funds that Congress specifically earmarked 15 for the TPPP. 16 Inc. versus Veneman, 310 F.3d 747, bridges that gap. 17 This case involves HHS's decision regarding But the D.C. Circuit's opinion in Milk Train, The Milk Train Court's decision makes it clear 18 that the principles behind Lincoln are not confined to 19 instances where Congress has made lump-sum appropriations, 20 that is, so long as Congress has left it to the agency's 21 sole judgment as to the manner in which funds should be 22 spent in order to reach the goals set out by Congress, the 23 agency's decisionmaking is presumptively unreviewable 24 because the agency's choice, among the many options for 25 allocating the funds, requires the same complicated balance 13 1 of factors that Lincoln discussed in the lump-sum 2 appropriation context. 3 In short, given the principles of Lincoln and 4 Milk Train, this Court concludes that HHS's decision to 5 shorten the project period and use the funds that would have 6 otherwise gone to a given project is the type of decision 7 that is presumptively unreviewable. 8 9 However, it is also clear to this Court that HHS's regulations do contain meaningful standards that constrain 10 HHS's discretion with respect to its grant-funding 11 decisions. 12 to review the agency's decisions in this regard. 13 These standards provide the Court with the means As the Court noted earlier, and as HHS conceded at 14 yesterday's hearing, if HHS has terminated the plaintiffs' 15 awards within the meaning of its regulations, then the 16 regulations apply and their standards render the agency's 17 decision reviewable by this Court. 18 So here is where I get to the part of the ruling 19 in which I announce the result because the Court has 20 concluded that HHS terminated plaintiffs' federal grants 21 within the meaning of the regulations. 22 conclusion for several reasons. 23 And I reach this First and foremost, there is the plain language of 24 the regulation itself. As defined in 45 CFR Section 75.2, a 25 "termination" means "the ending of a Federal award, in whole 14 1 or in part, at any time prior to the planned end of the 2 period of performance." 3 straightforward. 4 kind of shortening of the project period that HHS intended 5 to accomplish here. 6 This definition is fairly And, on its face, it describes exactly the This view is further bolstered by the provision in 7 the regulations that defines the phrase "period of 8 performance." 9 non-Federal entity may incur new obligations to carry out That phrase means: The time during which the 10 the work authorized under the Federal award. 11 the programatically approved five-year project period to me. 12 And, indeed, HHS's regulations expressly 13 cross-reference and equate the terms "period of performance" 14 and "project period." 15 regulation's definition of a "termination" as follows: 16 termination is the ending of a Federal award, in whole or in 17 part, at any time prior to the planned end of the project 18 period. 19 Sounds like Thus, one could easily rephrase the A Viewed in the light of the regulation's plain 20 language, the termination question in this case is thus a 21 fairly simple one. 22 question prior to the planned end of their project periods? 23 Even agency counsel admits that the answer to that question 24 is yes. 25 action, the agency itself said that this is precisely what Did HHS end the federal grants in And in fact, contemporaneously with the challenged 15 1 it was doing. 2 The Notices of Award that plaintiffs received in 3 July of 2017 stated, plainly and unequivocally, that "this 4 award shortens the project period to end on June 30, 2018." 5 Accordingly, it is clear beyond cavil that HHS 6 ended plaintiffs' grant awards two years before the planned 7 end of the project period, which is the same thing as saying 8 the agency ended the grants two years before the planned end 9 of the period of performance. And that is exactly what the 10 regulations call a termination of plaintiffs' federal 11 awards. 12 In an attempt to escape this conclusion, HHS 13 focuses on the funding aspect of the grant-making dynamic 14 which this Court finds odd to begin with because the 15 regulations plainly require that termination be assessed by 16 virtue of the status of the work to be performed, not the 17 status of the funding. 18 In any event, HHS insists that the period of 19 performance is the same as the one-year budget period 20 applicable to plaintiffs' projects, which lasts from 21 July 1st, 2017 to June 30, 2018. 22 that: 23 merely refused to provide the additional funding for the 24 remainder of the project period which, according to agency 25 counsel, HHS has every right to do under the terms of its And, therefore, HHS says Rather than terminating the grants, the agency has 16 1 2 Grant Policy Statement. The Court does see the policy statement language 3 upon which the agency purports to rely, and it has no doubt 4 that withholding funds in the best interest of the 5 Government was within the agency's announced position at the 6 time of plaintiffs' grant awards. 7 similar authority to refuse to make noncompeting 8 continuation awards during the planned period of performance 9 in the regulations. 10 But the Court finds no The words "budget period" do not appear in the 11 relevant regulations at all. 12 never equate the phrase "budget period" with the phrase 13 "period of performance," much less suggest that the 14 termination conditions are inapposite if the agency's 15 decision to shorten the project period is made at the end of 16 the annual budget cycle. 17 that appears to address the budget period is the Grant 18 Policy Statement. 19 undermine the agency's argument that the project period and 20 the budget period are one and the same because it states, 21 for example, on Page B-2, that the "budget period" is "the 22 interval of time into which a project period is divided for 23 budgetary and funding purposes." 24 25 And the regulations certainly And in fact, the only document And this document seems to simultaneously In any event, any such "budget period" definition cannot possibly supersede the regulations which, once again, 17 1 make no mention of budget and, instead, defines 2 "termination" as prematurely ending the period of 3 performance, and defines the "period of performance" as the 4 time period during which the grantee may incur obligations 5 under an HHS project. 6 This Court also notes that interpreting the phrase 7 "period of performance" to equate with the one-year budget 8 period -- which agency counsel urges me to do in the context 9 of this instant case -- appears to be entirely inconsistent 10 11 with HHS's past practice. How do I know this? I have reviewed various 12 Funding Opportunity Announcements that the agency created. 13 Not the one that plaintiffs' counsel gave me yesterday, by 14 the way, but the ones that are part of the instant record. 15 Looking at Page 39 of Exhibit N to the Sherman 16 Declaration, for example, in 2015, HHS stated that "grants 17 will be funded in annual increments (budget periods) and are 18 generally approved for a project period of up to five years. 19 And then, further down on that page, the agency notes that 20 the period for performance for these federal awards is not 21 to exceed five years and the budget period length was 12 22 months long. 23 This document, and other similar announcements, 24 plainly demonstrate that HHS has traditionally considered 25 the period of performance of grant-funded projects to extend 18 1 for a significantly longer time than the budget period. 2 in the context of the instant litigation, the agency has not 3 provided any document in which those two terms are actually 4 defined synonymously. 5 And What is more, the Funding Opportunity Announcement 6 previously referenced indicates that: Notwithstanding the 7 one-year budget period, the project period and period of 8 performance will not exceed five years, which makes imminent 9 sense given that HHS was soliciting scientific research 10 projects that inherently require significant time to 11 complete, and it is implausible that the agency intended 12 such projects to span only one year at the agency's 13 discretion. 14 One other argument that HHS makes is worthy of 15 mention at this time. 16 reference to "period of performance" must mean the one-year 17 budget period because, otherwise, the agency would incur 18 obligations to pay funds for future years in violation of 19 the Antideficiency Act. 20 HHS maintains the regulation's But this is not necessarily so. When it set up this grant program for 21 evidence-based research that promotes scientifically-proven 22 results, HHS not only expressly provided that continued 23 funding would be dependent upon the future availability of 24 funds through appropriation bills, it also went a step 25 further and required annual applications for continuation of 19 1 funding, check-ins that provide the agency with a chance to 2 ensure that it is not spending money it does not have. 3 further safeguard, it also appears that the agency actually 4 waits to confirm that Congress has appropriated the funds 5 for TPPP before it issues a Notice of Award notifying 6 plaintiffs that federal funds are available for their use in 7 that budget year. 8 9 As a This Court also notes that common sense dictates that the "budget period" and "period of performance" are not 10 intended to be the same thing. Through the TPP program -- 11 TPPP program that Congress has authorized and funded, HHS 12 gives grants for projects that scientific studies have 13 previously proven to reduce the rates of teen pregnancy 14 within communities, and it also finances research projects 15 to develop innovative new techniques to achieve this goal. 16 Neither of those objectives can be accomplished overnight. 17 And it strains credulity to suggest, as HHS does here, that 18 the agency ever intended these goals to be accomplished in a 19 single year. 20 successful and, thus, for the agency to be a good and 21 effective steward of the taxpayer dollars that it receives 22 from Congress for this purpose, the period of performance 23 and the competed-for -- excuse me -- the period of 24 performance for the competed-for teen pregnancy reduction 25 projects have to extend beyond just one year. For these projects to have any chance of being And the 20 1 agency's suggestion that it intends otherwise raises serious 2 doubts about the appropriate exercise of HHS's judgment with 3 respect to the funding of what the statute calls "medically 4 accurate and age-appropriate programs that reduce teen 5 pregnancy" which is one of the few requirements that 6 Congress has constantly and unequivocally imposed on HHS in 7 its annual appropriations bills. 8 9 This all means that HHS has ended plaintiffs' grant awards prior to the planned end of the projects' 10 period of performance such that the agency must be deemed to 11 have effected a termination per the agency's regulations. 12 And as agency counsel acknowledged during the hearing 13 yesterday, the agency's regulations quite clearly provide 14 that HHS may only terminate a grant award if: 15 grantee has failed to comply with the terms and conditions 16 of their award; or, two, HHS has caused to terminate the 17 grantee's awards; or, three, HHS has obtained the grantee's 18 consent to terminate the award; or, four, the grantee has 19 proposed the termination. 20 One, the This statutory set of criteria is a manageable 21 standard that cabins HHS's discretion and, thus, despite the 22 presumptive unreviewability that is applicable to this case, 23 a federal court can examine whether an agency has complied 24 with these standards. 25 of whether or not HHS's termination of plaintiffs' federal Which leads me to the merit question 21 1 grant awards was arbitrary and capricious within the meaning 2 of the Administrative Procedure Act. 3 I was happy that, during yesterday's hearing, 4 agency counsel and I appeared to view this question in the 5 same way. 6 Counsel readily admitted that if this Court found 7 that there was a termination, then the agency's action in 8 shortening plaintiffs' period of performance, as it did 9 here, clearly violates not only State Farm's requirement 10 that the agency provide a reasoned explanation for why it 11 took a particular course of action but, also, violates the 12 agency's own regulations insofar as HHS has not already 13 found that any of the four circumstances that I mentioned 14 exists. 15 The bottom line is this: For the purpose of this 16 expedited oral ruling, it suffices to say that, in this 17 Court's view, if HHS's programatic approval of a five-year 18 project period subject to a one-year budget period means 19 anything, then it has to mean that the work projects that 20 plaintiffs proposed to the agency in their initial 21 competitive applications were approved prospectively for the 22 ensuing five-year period, notwithstanding the fact that the 23 projects were going to be funded incrementally during 24 one-year budget cycles. 25 agency's programatic approval carries forward through the And per the regulations, the 22 1 prescribed period of performance so long as Congress 2 appropriates the funds and none of the specific grounds for 3 termination arises. 4 The agency's suggestion here that despite the 5 five-year programmatic approval that it gave plaintiffs' 6 grant projects, HHS has the authority to repeatedly 7 reevaluate its approval decision on an annual basis in the 8 context of the budgeting process must be rejected not only 9 because it is manifestly inconsistent with the agency's past 10 practices and the realities of federally-funded scientific 11 research projects, but also because it appears nowhere in 12 the plain language of the regulations that unquestionably 13 govern the agency's actions with respect to the grant-making 14 process. 15 Furthermore, whatever the agency's Grant Policy 16 Statement might be read to mean, when it indicates that HHS 17 may decide not to make a noncompeting continuation award 18 within the current competitive segment, this Court finds 19 that HHS did no such thing here. 20 contemporaneously characterized its own actions as 21 shortening plaintiffs' project periods to end on June 30, 22 2018, which is two years earlier than the period of 23 performance that the agency had previously approved. 24 25 And, instead, it All of this considered, this Court believes that there can be no other conclusion but that HHS ended 23 1 plaintiffs' federal award, in whole or in part, prior to the 2 planned end of the period of performance thereby terminating 3 plaintiffs' grant awards under the regulations and that it 4 did so without explanation, much less a finding of any of 5 the causes that the agency's own regulations prescribe. 6 That is arbitrary and capricious action. 7 Therefore, plaintiffs' motion for summary judgment 8 must be granted, and defendant's cross-motion for summary 9 judgment must be denied. 10 The Court's order on these motions, which will 11 issue today, will further mandate that the agency's decision 12 to shorten the project period for the plaintiffs' awards is 13 vacated, and that the agency shall continue accepting and 14 processing the plaintiffs' noncompeting continuation 15 applications in the same way that it has in past years. 16 Now, as a procedural matter, I want to make clear 17 that this is a final appealable order, and the parties 18 should take that into account when evaluating their options. 19 I have given you the broad outline of my 20 reasoning. 21 written opinion as soon as practicable. 22 meantime, you will have to decide whether to comply or to 23 appeal based on my ruling and the findings that I have 24 articulated here today. 25 And I will do my best to provide you with a But, in the Is there anything else that needs to be addressed 24 1 in this matter at this time? 2 MR. GERARDI: 3 THE COURT: 4 MR. GERARDI: 5 THE COURT: 6 For those on the phone, this is Mr. Gerardi. 7 MR. GERARDI: 8 The Government would like to request a delay in 9 10 One thing briefly, Your Honor. Yes. May I approach? You may. Thank you, Your Honor. the effective date of the order of one week. To be clear, as we've discussed, the Government 11 has committed to accepting the plaintiffs' applications for 12 noncompeting funding; and we will continue to process them 13 under that commitment. 14 At the same time, the agency is in the middle of 15 planning its re-competition of funds under this program. 16 The process is time sensitive. 17 end of the federal fiscal year, and the Government needs 18 time to evaluate the Court's ruling to determine whether an 19 appeal should happen at all, and what the effect of the 20 order will have on this competitive application process. 21 we would respectfully request that the effective date of the 22 order be delayed by a week. 23 Mr. Sherman. 24 THE COURT: 25 MR. SHERMAN: As you know, it's key to the And, of course, I yield to Mr. Sherman. Thank you, Your Honor. So 25 1 Respectfully, plaintiffs don't agree to the 2 request and would ask the Court to issue the order 3 immediately, not with a delay. 4 As we've discussed, Your Honor, with respect to 5 scheduling the hearing and the decision, time is really of 6 the essence. 7 order to accept and process the applications, it needed a 8 certain amount of time to do it and to make sure that 9 plaintiffs didn't have any sort of gap in their funding. 10 HHS has already indicated previously that, in THE COURT: But HHS also agreed to do that as a 11 part of our discussion of whether or not we needed to treat 12 this as a preliminary injunction motion or not. 13 understanding that -- you might tell me otherwise. 14 my understanding that the agency has been accepting and 15 processing your applications. 16 MR. SHERMAN: 17 but they have not processed them. So it's my But it's Your Honor, they have accepted them, 18 The agreement that we had reached with HHS and our 19 understanding of what HHS had done thus far is that they had 20 accepted them and were awaiting Your Honor's ruling. 21 Your Honor had issued a ruling that was favorable then, at 22 that time, the agency would begin processing the 23 applications but that the agency was just accepting them 24 until that time. 25 THE COURT: All right. If But let me ask you how you 26 1 are prejudiced by a one-week delay in their processing? 2 If, for example, the agency says, nevertheless, we 3 will -- if we decide not to appeal, or whatever, or if we 4 win on appeal -- on an emergency appeal, we will still get 5 the Notices of Award to you within the same time frame as 6 envisioned initially. 7 if they don't start today, in terms of the processing? 8 What difference does it make to you MR. SHERMAN: Your Honor, I think you are right 9 that if -- we wouldn't be prejudiced to the extent that it 10 would not delay the funding in any way or that if somehow 11 this delay that the agency is seeking would delay their 12 decision to appeal, which would then delay a subsequent even 13 expedited appeal, and then there would be a gap in funding 14 because of this delay. 15 stay -- 16 THE COURT: For example, if they then sought a You would have to argue that at that 17 time. 18 moment, the question that the agency has posed is whether 19 they can have a week before they begin to start processing 20 this. 21 I mean, from the vantage point where I sit at this I don't see how that harms plaintiffs. MR. SHERMAN: I think that's right. As long as 22 the agency confirms that they can get it done in the time 23 period that there wouldn't be a gap, then I think you are 24 right, the plaintiffs wouldn't suffer prejudice, Your Honor. 25 THE COURT: All right. Mr. Gerardi, can the 27 1 agency still get it done? If you decide not to appeal or if 2 you appeal and you lose, are we still going to be able to 3 get the plaintiffs their money in the ordinary course? 4 MR. GERARDI: We should, Your Honor. 5 We have other litigation on this topic where a 6 hearing is not even scheduled until mid next week. 7 have made similar representations to plaintiffs in those 8 cases that we will get the processing done. 9 understand, the week is so we can obtain -- if we decide to 10 appeal, we would obviously need necessary approval in order 11 to file a motion to stay, which would be a necessary 12 component in any necessary appeal. 13 THE COURT: 14 MR. GERARDI: 15 THE COURT: And we Just to I understand. So yes. The answer is yes. So your motion is granted, insofar as 16 you're asking for an additional week before my order becomes 17 effective. 18 to produce my opinion in the week that I am now giving you. 19 Let me say, I am not going to be able, likely, I am in trial starting Monday. My schedule is 20 such that I had hoped to have given you enough orally now in 21 order for you to be able to make your appellate decision. 22 MR. GERARDI: Your Honor, I think the oral ruling 23 is sufficient for us to go forward and make a determination. 24 And we appreciate the effort that you put into that today. 25 THE COURT: All right. So you will have an 28 1 additional week. I will set up my order so that it becomes 2 effective a week from today. 3 Is there anything else we need to address? 4 MR. SHERMAN: No, Your Honor. 5 MR. GERARDI: Nothing further, Your Honor. 6 THE COURT: 7 All right. Thank you. You are excused. 8 (Whereupon, the proceeding concludes, 10:21 a.m.) 9 * * * * * 10 CERTIFICATE 11 12 I, ELIZABETH SAINT-LOTH, RPR, FCRR, do hereby 13 certify that the foregoing constitutes a true and accurate 14 transcript of my stenographic notes, and is a full, true, 15 and complete transcript of the proceedings to the best of my 16 ability. 17 18 19 Dated this 20th day of April, 2018. 20 21 22 23 24 25 /s/ Elizabeth Saint-Loth, RPR, FCRR Official Court Reporter